BRNS
HEALTHCAREBarinthus Biotherapeutics Plc.
$0.66+0.00 (+0.38%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BRNS Today?
No stock-specific AI insight has been generated for BRNS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.51$2.91
$0.66
Fundamentals
Market Cap$27M
P/E Ratio—
EPS$-1.29
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume42K
Avg Volume (10D)—
Shares Outstanding40.8M
BRNS News
12 articles- Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate DevelopmentsYahoo Finance·Apr 30, 2026
- Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate DevelopmentsYahoo Finance·Mar 13, 2026
- Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·Dec 15, 2025
- Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac DiseaseYahoo Finance·Dec 10, 2025
- Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate DevelopmentsYahoo Finance·Nov 7, 2025
- ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus TherapeuticsYahoo Finance·Oct 24, 2025
- Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune DiseasesYahoo Finance·Sep 30, 2025
- Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate DevelopmentsYahoo Finance·Aug 7, 2025
- Broadwind Leads The Charge With 2 Other Prominent Penny StocksYahoo Finance·Jul 17, 2025
- Q2 Virtual Investor Summit: Presentations Available NowYahoo Finance·Jun 25, 2025
- Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025Yahoo Finance·Jun 9, 2025
- Metalpha Technology Holding And 2 Other Promising Penny StocksYahoo Finance·Jun 2, 2025
All 12 articles loaded
Price Data
Open$0.70
Previous Close$0.66
Day High$0.70
Day Low$0.63
52 Week High$2.91
52 Week Low$0.51
52-Week Range
$0.51$2.91
$0.66
Fundamentals
Market Cap$27M
P/E Ratio—
EPS$-1.29
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume42K
Avg Volume (10D)—
Shares Outstanding40.8M
About Barinthus Biotherapeutics Plc.
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company is headquartered in Harwell, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—